Skip to content

Kateřina Hájková

14 papers in the library · 378 citations · publishing 2016-2026

Papers

Sort Most recent Most cited

The effects of psilocybin on time perception in humans: A comparative analysis of subjective and objective measures

Journal of Psychopharmacology 2026 Petr Scholle, Štěpán Wenke, Tereza Nekovářová et al. 1 citation

Background: Although psychedelics have regained attention as potential treatment tools for various mental disorders, little research has examined their impact on temporal perception. Aims: This double-blinded placebo-controlled study aimed to investigate changes in temporal perception under psilocybin, both through performance during the Temporal Bisection Task (TBT) and through subjective...

The phenomenology of psilocybin's experience mediates subsequent persistent psychological effects independently of sex, previous experience, or setting.

Pharmacological Reports June 16, 2025 Tereza Klučková, Marek Nikolič, Filip Tylš et al. 4 citations

Recent studies intensively explore psilocybin's antidepressant potential, but variables like previous experience, repeated use, setting, and sex remain underexplored. This study examines acute and long-term effects of psilocybin in healthy individuals. A double-blind, placebo-controlled, cross-over study included 40 healthy participants (20 females, mean age 38). Each received two doses of...

DOI: 10.1007/s43440-025-00742-5 (opens in new tab) Full text (opens in new tab) Healthy population Previous experience Repeated administration Sex +7

DETERMINATION OF TRYPTAMINE ALKALOIDS AND THEIR STABILITY IN PSYCHOTROPIC MUSHROOMS

The International Journal of Neuropsychopharmacology February 1, 2025 Martin Kuchař, Klara Gotwaldova, Jan Borovička et al. 1 citation

Abstract Synthetic psilocybin (PSB), but also the PSB-containing mushrooms are used for psychedelic therapy and microdosing. It is necessary to know alkaloids variability and stability in wild-grown mushrooms. Concentrations of other psychotropic (or potentially psychotropic) tryptamines such as psilocin (PS), baeocystin (BA), norbaeocystin (NB), and aeruginascin (AE) are also relevant. This...

Acute pharmacological profile of 2C-B-Fly-NBOMe in male Wistar rats-pharmacokinetics, effects on behaviour and thermoregulation.

Frontiers in Pharmacology 2023 Kateřina Syrová, Klára Šíchová, Hynek Danda et al. 4 citations

Introduction: N-2-methoxy-benzylated ("NBOMe") analogues of phenethylamine are a group of new psychoactive substances (NPS) with reported strong psychedelic effects in sub-milligram doses linked to a number of severe intoxications, including fatal ones. In our present work, we provide a detailed investigation of pharmacokinetics and acute behavioural effects of 2C-B-Fly-NBOMe...

DOI: 10.3389/fphar.2023.1120419 (opens in new tab) Full text (opens in new tab) 2c-b-fly-nbome Nbome series New psychoactive substance Pharmacokinetics +10

Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids

International Journal of Molecular Sciences November 15, 2022 Klára Gotvaldová, Jan Borovička, Kateřina Hájková et al. 50 citations

Since not only psilocybin (PSB) but also PSB-containing mushrooms are used for psychedelic therapy and microdosing, it is necessary to know their concentration variability in wild-grown mushrooms. This article aimed to determine the PSB, psilocin (PS), baeocystin (BA), norbaeocystin (NB), and aeruginascin (AE) concentrations in a large sample set of mushrooms belonging to genera previously...

DOI: 10.3390/ijms232214068 (opens in new tab) Psilocybin Tryptamines Mushroom Agaricales +4

Psilocybin—Mediated Attenuation of Gamma Band Auditory Steady-State Responses (ASSR) Is Driven by the Intensity of Cognitive and Emotional Domains of Psychedelic Experience

Journal of Personalized Medicine June 19, 2022 Vojtěch Viktorin, Inga Griškova-bulanova, Aleksandras Voicikas et al. 19 citations

Psilocybin is a classical serotoninergic psychedelic that induces cognitive disruptions similar to psychosis. Gamma activity is affected in psychosis and is tightly related to cognitive processing. The 40 Hz auditory steady-state responses (ASSR) are frequently used as indicators to test the ability to generate gamma activity. Based on previous literature, we studied the impact of psilocybin on...

Pharmacokinetic, pharmacodynamic, and behavioural studies of deschloroketamine in Wistar rats.

British Journal of Pharmacology 2022 Kristýna Štefková-mazochová, Hynek Danda, Wim Dehaen et al. 13 citations

Deschloroketamine (DCK), a structural analogue of ketamine, has recently emerged on the illicit drug market as a recreational drug with a modestly long duration of action. Despite it being widely used by recreational users, no systematic research on its effects has been performed to date. Pharmacokinetics, acute effects, and addictive potential in a series of behavioural tests in Wistar rats...

DOI: 10.1111/bph.15680 (opens in new tab) Full text (opens in new tab) Nmda receptor Deschloroketamine Enantiomers Locomotion +2

Psilocybin microdosing does not affect emotion-related symptoms and processing: A preregistered field and lab-based study

Journal of Psychopharmacology December 17, 2021 Josephine Marschall, George Fejer, Pascal Lempe et al. 69 citations

Background: Microdoses of psychedelics (i.e. a sub-hallucinogenic dose taken every third day) can reduce symptoms of depression, anxiety and stress according to anecdotal reports and observational studies. Research with medium to high doses of psilocybin points towards potential underlying mechanisms, including the modulation of emotion and interoceptive processing. Aims: In this preregistered...

Effects of psilocybin microdosing on awe and aesthetic experiences: a preregistered field and lab-based study

Psychopharmacology April 30, 2021 Michiel van Elk, George Fejer, Pascal Lempe et al. 53 citations

Abstract There is an increased societal trend to engage in microdosing, in which small sub-hallucinogenic amounts of psychedelics are consumed on a regular basis. Following subjective reports that microdosing enhances the experience of nature and art, in the present study we set out to study the effects of psilocybin microdosing on feelings of awe and art perception. In this preregistered...

Stability of psilocybin and its four analogs in the biomass of the psychotropic mushroom Psilocybe cubensis

Drug Testing and Analysis October 29, 2020 Klára Gotvaldová, Kateřina Hájková, Jan Borovička et al. 69 citations

Abstract Psilocybin, psilocin, baeocystin, norbaeocystin, and aeruginascin are tryptamines structurally similar to the neurotransmitter serotonin. Psilocybin and its pharmacologically active metabolite psilocin in particular are known for their psychoactive effects. These substances typically occur in most species of the genus Psilocybe (Fungi, Strophariaceae). Even the sclerotia of some of...

DOI: 10.1002/dta.2950 (opens in new tab) Psilocybin Tryptamines Mushroom Metabolite +2

Behavioral and Pharmacokinetic Profile of Indole-Derived Synthetic Cannabinoids JWH-073 and JWH-210 as Compared to the Phytocannabinoid Δ9-THC in Rats

Frontiers in Neuroscience October 23, 2018 Libor Uttl, Ewa Szczurowska, Kateřina Hájková et al. 24 citations

Synthetic cannabinoid compounds are marketed as ‘legal’ marijuana substitutes, even though little is known about their behavioral effects in relation to their pharmacokinetic profiles. Therefore, in the present study we investigated the behavioral effects of systemic treatment with the two synthetic cannabinoids JWH-073 and JWH-210 and the phytocannabinoid Δ9-THC on locomotor activity and...

Behavioural, Pharmacokinetic, Metabolic, and Hyperthermic Profile of 3,4-Methylenedioxypyrovalerone (MDPV) in the Wistar Rat

Frontiers in Psychiatry April 24, 2018 Rachel R. Horsley, Eva Lhotková, Kateřina Hájková et al. 20 citations

3,4-methylenedioxypyrovalerone (MDPV) is a potent pyrovalerone cathinone that is substituted for amphetamines by recreational users. We report a comprehensive and detailed description of the effects of subcutaneous MDPV (1-4 mg/kg) on pharmacokinetics, biodistribution and metabolism, acute effects on thermoregulation under isolated and aggregated conditions, locomotion (open field) and sensory...

DOI: 10.3389/fpsyt.2018.00144 (opens in new tab) Pharmacokinetics Pharmacology Thermoregulation Cathinone +6

Synthesis of methoxetamine, its metabolites and deuterium labelled analog as analytical standards and their HPLC and chiral capillary electrophoresis separation

RSC Advances 2017 Bronislav Jurásek, Michal Himl, Radek Jurok et al. 13 citations

Methoxetamine, a designer drug marketed as a replacement for the dissociative anaesthetic ketamine, has been associated with significant numbers of hospital related intoxications and deaths in Europe.

DOI: 10.1039/c7ra10893a (opens in new tab) Ketamine Capillary electrophoresis Enantiomer High-performance liquid chromatography +3

Detailed pharmacological evaluation of methoxetamine (MXE), a novel psychoactive ketamine analogue—Behavioural, pharmacokinetic and metabolic studies in the Wistar rat

Brain Research Bulletin May 4, 2016 Rachel R. Horsley, Eva Lhotková, Kateřina Hájková et al. 38 citations

Methoxetamine (MXE) is a novel psychoactive compound (NPS) that emerged in 2010 as a substitute for the dissociative anaesthetic ketamine. MXE has a reputation of carrying a lower risk of harm than ketamine, however a number of deaths have been reported. Currently very little is known about the psychopharmacological effects of this compound or its toxicity; therefore we tested, in Wistar rats,...